We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Enviri
NVRI
$607M
| $22.4M | 0.06% |
2,269,074
-475,892
| -17% | -$3.92M |
|
352
STMicroelectronics
STM
$42.6B
| $22.3M | 0.06% |
+445,862
| New | +$20.7M |
|
353
SIGA Technologies
SIGA
$218M
| $22.2M | 0.06% |
4,404,648
+1,591,963
| +57% | +$9.05M |
|
354
Interactive Brokers
IBKR
$41.1B
| $22.1M | 0.05% |
1,065,588
+144,296
| +16% | +$2.85M |
|
|
ATYR
355
aTyr Pharma
ATYR
$38.1M
| $22M | 0.05% |
10,189,966
| – | – |
|
356
Texas Roadhouse
TXRH
$11.9B
| $22M | 0.05% |
195,781
+14,793
| +8% | +$1.63M |
|
357
Incyte
INCY
$24.8B
| $22M | 0.05% |
352,627
+312,733
| +784% | +$20.9M |
|
358
Charles River Laboratories
CRL
$13.3B
| $21.9M | 0.05% |
104,372
-22,423
| -18% | -$4.46M |
|
359
AbCellera Biologics
ABCL
$3.62B
| $21.8M | 0.05% |
3,374,055
+469,796
| +16% | +$3.21M |
|
|
GAP
360
The Gap Inc
GAP
$7.35B
| $21.7M | 0.05% |
2,431,707
-47,577
| -2% | -$424K |
|
|
DCBO
361
Docebo
DCBO
$605M
| $21.7M | 0.05% |
549,449
| – | – |
|
362
Hewlett Packard
HPE
$73.6B
| $21.7M | 0.05% |
1,288,858
+4,344
| +0.3% | +$66.4K |
|
363
Emcor
EME
$34.4B
| $21.5M | 0.05% |
116,594
-7,454
| -6% | -$1.25M |
|
364
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.8B
| $21.5M | 0.05% |
860,694
-147,266
| -15% | -$3.86M |
|
365
MP Materials
MP
$9.03B
| $21.5M | 0.05% |
939,298
+693,324
| +282% | +$15.9M |
|
366
Mercado Libre
MELI
$96.3B
| $21.4M | 0.05% |
18,090
-2,347
| -11% | -$2.95M |
|
367
ScottsMiracle-Gro
SMG
$3.26B
| $21.4M | 0.05% |
341,158
+71,943
| +27% | +$4.82M |
|
368
A.O. Smith
AOS
$7.8B
| $21.3M | 0.05% |
293,212
-13,208
| -4% | -$904K |
|
369
Natera
NTRA
$47.4B
| $21.3M | 0.05% |
438,263
+42,162
| +11% | +$2.15M |
|
|
WCC
370
WESCO International
WCC
$16.4B
| $21.3M | 0.05% |
118,872
+3,847
| +3% | +$561K |
|
371
Kinsale Capital Group
KNSL
$8.29B
| $21.2M | 0.05% |
56,782
+9,575
| +20% | +$3.18M |
|
372
AstraZeneca
AZN
$254B
| $21.2M | 0.05% |
148,412
+242
| +0.2% | +$35.6K |
|
|
ENV
373
DELISTED
ENVESTNET, INC.
ENV
| $21.1M | 0.05% |
356,296
-1,851
| -0.5% | -$107K |
|
374
PROG Holdings
PRG
$1.47B
| $21.1M | 0.05% |
656,860
-38,276
| -6% | -$1.15M |
|
375
AutoZone
AZO
$47B
| $21.1M | 0.05% |
8,454
-113
| -1% | -$288K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.